Literature DB >> 15468758

Statistical methods for analyzing tissue microarray data.

Xueli Liu1, Vladimir Minin, Yunda Huang, David B Seligson, Steve Horvath.   

Abstract

Tissue microarrays (TMAs) are a new high-throughput tool for the study of protein expression patterns in tissues and are increasingly used to evaluate the diagnostic and prognostic importance of biomarkers. TMA data are rather challenging to analyze. Covariates are highly skewed, non-normal, and may be highly correlated. We present statistical methods for relating TMA data to censored time-to-event data. We review methods for evaluating the predictive power of Cox regression models and show how to test whether biomarker data contain predictive information above and beyond standard pathology covariates. We use nonparametric bootstrap methods to validate model fitting indices such as the concordance index. We also present data mining methods for characterizing high risk patients with simple biomarker rules. Since researchers in the TMA community routinely dichotomize biomarker expression values, survival trees are a natural choice. We also use bump hunting (patient rule induction method), which we adapt to the use with survival data. The proposed methods are applied to a kidney cancer tissue microarray data set.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15468758     DOI: 10.1081/BIP-200025657

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  24 in total

1.  Patient subgroup identification for clinical drug development.

Authors:  Xin Huang; Yan Sun; Paul Trow; Saptarshi Chatterjee; Arunava Chakravartty; Lu Tian; Viswanath Devanarayan
Journal:  Stat Med       Date:  2017-02-01       Impact factor: 2.373

2.  Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.

Authors:  Maoyong Fu; Erin L Maresh; Robert A Soslow; Mohammad Alavi; Vei Mah; Qin Zhou; Alexia Iasonos; Lee Goodglick; Lynn K Gordon; Jonathan Braun; Madhuri Wadehra
Journal:  Clin Cancer Res       Date:  2010-08-01       Impact factor: 12.531

Review 3.  DNA microarrays: recent developments and applications to the study of pituitary tissues.

Authors:  Xiang Qian; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

4.  Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Authors:  Julian C Y Ip; Tony C Y Pang; Anthony R Glover; Patsy Soon; Jing Ting Zhao; Stephen Clarke; Bruce G Robinson; Anthony J Gill; Stan B Sidhu
Journal:  Oncologist       Date:  2015-02-05

Review 5.  Applications and continued evolution of glycan imaging mass spectrometry.

Authors:  Colin T McDowell; Xiaowei Lu; Anand S Mehta; Peggi M Angel; Richard R Drake
Journal:  Mass Spectrom Rev       Date:  2021-08-15       Impact factor: 10.946

6.  Global levels of histone modifications predict prognosis in different cancers.

Authors:  David B Seligson; Steve Horvath; Matthew A McBrian; Vei Mah; Hong Yu; Sheila Tze; Qun Wang; David Chia; Lee Goodglick; Siavash K Kurdistani
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

7.  Reconstructing tumor-wise protein expression in tissue microarray studies using a Bayesian cell mixture model.

Authors:  Ronglai Shen; Jeremy M G Taylor; Debashis Ghosh
Journal:  Bioinformatics       Date:  2008-10-14       Impact factor: 6.937

8.  Modeling intra-tumor protein expression heterogeneity in tissue microarray experiments.

Authors:  Ronglai Shen; Debashis Ghosh; Jeremy M G Taylor
Journal:  Stat Med       Date:  2008-05-20       Impact factor: 2.373

9.  Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.

Authors:  Nam K Yoon; David B Seligson; David Chia; Yahya Elshimali; Giri Sulur; Ai Li; Steve Horvath; Erin Maresh; Vei Mah; Shikha Bose; Benjamin Bonavida; Lee Goodglick
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

Review 10.  From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.

Authors:  Androu Arsanious; Georg A Bjarnason; George M Yousef
Journal:  Mol Cancer       Date:  2009-03-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.